Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1312, Issue 3, 1996, Pages 186-196

  Konopka, Krystyna ^a   Pretzer, Elizabeth ^a   Felgner, Philip L ^c   Düzgüneş, Nejat ^a,b  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VICAL INC   (United States)

Author keywords

Cationic liposome; Cytotoxicity; HIV 1; Human; Macrophage

Indexed keywords

CATION; LIPOSOME;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

EID: 0030600235     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-4889(96)00033-X     Document Type: Article

References (60)

1. [1] Singhal, A. and Huang, L. (1994) in: Gene Therapeutics: Methods and Applications of Direct Gene Transfer (Wolff, J.A., ed.), pp. 118-142, Birkhäuser, Boston.
2. [2] Farhood, H., Gao, X., Son, K., Yang, Y.-Y., Lazo, J.S., Huang, L., Barsoum, J., Bottega, R. and Epand, R.M. (1994) Ann. NY Acad. Sci. 716, 23-35.
3. [3] Felgner, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, G.M. and Danielsen, M. (1987) Proc. Natl. Acad. Sci. USA 84, 7413-7417.
4. [4] Felgner, P.L. and Ringold, G.M. (1989) Nature 337, 387-388.
5. [5] Felgner, P.L. (1990) Adv. Drug Deliv. Rev. 5, 163-187.
6. [6] Düzgüneş, N. and Felgner, P.L. (1993) Methods Enzymol. 221, 303-306.
7. [7] Smith, J.G., Walzem, R.L. and German, J.B. (1993) Biochim. Biophys. Acta 1154, 327-340.
8. [8] Malone, R.W., Felgner, P.L. and Verma, I.M. (1989) Proc. Natl. Acad. Sci. USA 86, 6077-6081.
9. [9] Leserman, L. (1995) In: Liposomes as Tools in Basic Research and Industry (Philippot, J.R. and Schuber, F., eds.), pp. 215-223, CRC Press, Boca Raton, Florida.
10. [10] Debs, R.J., Freedman, L.P., Edmunds, S., Gaensler, K.L., Düzgüneş, N. and Yamamoto, K.R. (1990) J. Biol. Chem. 265, 10189-10192.
11. [11] Lin, M.-F., DaVolio, J. and Garcia R. (1993) Biochem. Biophys. Res. Commun. 192, 413-419.
12. [12] Brigham, K.L., Meyrick, B., Christman, B., Magnuson, M., King, G. and Berry, L.C., Jr. (1989) Am. J. Med. Sci. 298, 278-281.
13. [13] Stewart, M.J., Plautz, G.E., Del Buono, L., Yang, Z.Y., Xu, L., Gao, X., Huang, L., Nabel, E.G. and Nabel, G.J. (1992) Hum. Gene Ther. 3, 267-275.
14. [14] Nabel, E.G., Gordon, D., Yang, Z.-Y., Xu, L., San, H., Plautz, G.E., Wu, B.-Y., Gao, X., Huang, L. and Nabel, G.J. (1992) Hum. Gene Ther. 3, 649-656.
15. [15] Philip, R., Liggitt, D., Philip, M., Dazin, P. and Debs, R. (1993) J. Biol. Chem. 268, 16087-16090.
16. [16] Nabel, G.J., Chang, A., Nabel, E.G., Plautz, G., Fox, B.A., Huang, L. and Shu, S. (1992) Hum. Gene Ther. 3, 399-410.
17. [17] Farhood, H., Bottega, R., Epand, R.M. and Huang, L. (1992) Biochim. Biophys. Acta 1111, 230-246.
18. [18] Remy, J.-S., Sirlin, C. and Behr, J.-P. (1995) In: Liposomes as Tools in Basic Research and Industry (Philippot, J.R. and Schuber, F. eds.), pp. 159-170, CRC Press Inc.
19. [19] Konopka, K., Stamatatos, L., Larsen, C.E., Davis, B.R. and Düzgüneş, N. (1991) J. Gen. Virol. 72, 2685-2696.
20. [20] Stamatatos, L., Leventis, R., Zuckermann, M.J. and Silvius, J.R. (1988) Biochemistry 27, 3917-3925.
21. [21] Düzgüneş, N., Goldstein, J.A., Friend, D.S. and Felgner, P.L. (1989) Biochemistry 28, 9179-9184.
22. [22] Leventis, R. and Silvius, J.R. (1990) Biochim. Biophys. Acta 1023, 124-132.
23. [23] Wrobel, I. and Collins, D. (1995) Biochim. Biophys. Acta 1235, 296-304.
24. [24] Pinnaduwage, P., Schmitt, L. and Huang, L. (1989) Biochim. Biophys. Acta 985, 33-37.
25. [25] Rose, J.K., Buonocore, L. and Whitt, M.A. (1991) Biotechniques 10, 520-525.
26. [26] Legendre, J.-Y. and Szoka, F.C. (1992) Pharm. Res. 9, 1235-1242.
27. [27] Capecchi, M.R. (1980) Cell 22, 535-565.
28. [28] Friend, D.S., Debs, R.J. and Düzgüneş, N. (1990) J. Cell Biol. 111, 119a (Abstr.).
29. [29] Bennett, C.F., Chiang, M.Y. Chan, H., Shoemaker, J.E.E. and Mirabelli, C.K. (1992) Mol. Pharmacol. 41, 1023-1033.
30. [30] Gartner, S., Markovits, P., Markovitz, D.M., Kaplan, M.H., Gallo, R.C. and Popovic, M. (1986) Science 233, 215-219.
31. [31] Ho, D.D., Rosa, T.R. and Hirsch, M.S. (1986) J. Clin. Invest. 77, 1712-1715.
32. [32] Meltzer, M.S., Skillman, D.R., Gomatos, P.J., Kalter, D.C. and Gendelman, H.E. (1990) Annu. Rev. Immunol. 8, 169-194.
33. [33] Meltzer, M.S. and Gendelman, H.E. (1992) Curr. Top. Microbiol. Immunol. 181, 239-263.
34. [34] Crowe, S.M. and Kornbluth, R.S. (1994) J. Leukocyte Biol. 56, 215-217.
35. [35] Konopka, K., Pretzer, E., Felgner, P. and Düzgüneş, N. (1995) J. Cell. Biochem. Suppl. 21B, 193 (Abstr.).
36. [36] Hawley-Nelson, P., Ciccarone, V., Gebeyehu, G., Jesse, J. and Felgner, P.L. (1993) Focus 15, 73-79.
37. [37] Felgner, J.H., Kumar, R., Sridhar, C.N., Wheeler, C.J., Tsai, Y.J., Border, R., Ramsey, P., Martin, M. and Felgner, P.L. (1994) J. Biol. Chem. 269, 2550-2561.
38. [38] Konopka, K., Davis, B.R., Larsen, C.E., Alford, D.R., Debs, R.J. and Düzgüneş, N. (1990) J. Gen. Virol. 71, 2899-2907.
39. [39] Konopka, K., Pretzer, E., Plowman, B. and Düzgüneş, N. (1993) Virology 193, 877-887.
40. [40] Fields, R.D. and Lancaster, M.V. (1993) Am. Biotechnol. Lab. 11, 48-50.
41. [41] Ahmed, S.A., Gogal R.M., and Walsh, J.E. (1994) J. Immunol. Methods 170, 211-224.
42. [42] Benghuzzi, H.A. (1995) Biomed. Sci. Instrumentation 31, 121-126.
43. [43] Nakagawara, A. and Nathan C.F. (1983) J. Immunol. Methods 56, 261-268.
44. [44] Perno, C.F., Bergamini, A., Pesce, C.D., Milanese, G., Capozzi, M., Aquaro, S., Thaisrivongs, S., Tarpley, W.G., Zon, G., D'Agostini, C., Rocchi, G., Garaci, E. and Calio, R. (1993) J. Infect. Dis. 168, 1148-1156.
45. [45] Poste, G., Bucana, C., Raz, A., Bugelski, P., Kirsh, R. and Fidler, I.J. (1982) Cancer Res. 42, 1412-1422.
46. [46] Roerdink, F., Regts, J., Daemen, T., Bakker-Woudenberg, I. and Scherphof, G. (1986) In: Targeting of Drugs with Synthetic Systems (Gregoriadis, G., Senior, J. and Poste, G., eds.), pp. 193-206, Plenum Press, New York.
47. [47] Lee, K.-D., Nir, S. and Papahadjopoulos D. (1993) Biochemistry 32, 889-899.
48. [48] Yoshihara, E. and Nakae, T. (1986) Biochim. Biophys. Acta 854, 530-546.
49. [49] Lappalainen, K., Jääskeläinen, I., Syrjänen, K., Urtti, A. and Syrjänen, S. (1994) Pharm. Res. 11, 1127-1131.
50. [50] Lappalainen, K., Urtti, A., Jääskeläinen, I., Syrjänen, K. and Syrjänen, S. (1994) Antiviral Res. 23, 119-130.
51. [51] Gibco BRL Cationic Lipid Reagents. Guide to Eukaryotic Transfections with Cationic Lipid Reagents. Life Technologies, Inc., Gaithersburg, MD.
52. [52] Brunette, E., Stribling, R. and Debs, R. (1992) Nucleic Acid Res. 20, 1151.
53. [53] Ciccarone, V., Hawley-Nelson, P. and Jessee, J. (1993) Focus 15, 80-83.
54. [54] Kitano, K., Baldwin, G.C., Raines, M.A. and Golde, D.W. (1990) Blood 76, 1980-1988.
55. [55] Mikovits, J.A., Raziuddin, M.G., Ruta, M., Lohrey, N.C., Kung, H.-F. and Ruscetti, F.W. (1990) J. Exp. Med. 171, 1705-1720.
56. [56] Meylan, P.R.A., Spina, C.A., Richman, D.D. and Kornbluth R.S. (1993) Virology 93, 256-267.
57. [57] Auwerx, J. (1991) Experientia 47, 22-31.
58. [58] Tsuchiya, S., Kobayashi, Y., Goto, Y., Okumura, H., Nakae, C., Konno, T. and Tada, K. (1982) Cancer Res. 42, 1530-1536.
59. [59] Valentin, A., Nilsson, K. and Asjö, B. (1994) J. Leuk. Biol. 56, 225-229.
60. [60] Konopka, K., Rossi, J.J., Felgner, P. and Düzgüneş, N. (1995) Antiviral Res. 26, A266 (Abstr.).